Cargando…
Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment
Colorectal cancer (CRC) is the third most prevalent one in the world among the most common malignant tumors. Numerous studies have shown that butyrate has demonstrated promise as an antitumor agent in a variety of human cancer types. However, butyrate remains understudied in CRC tumorigenesis and pr...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060236/ https://www.ncbi.nlm.nih.gov/pubmed/36991138 http://dx.doi.org/10.1038/s41598-023-32457-z |